Standard Biotools Inc. (lab 2.75 02/01/34)
13F holders, Q2 2024 (June 30)4holders +2
2new positions
0sold out
$0.99avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Standard Biotools Inc. (lab 2.75 02/01/34) in their 13F filings, up 2 from Q1 2024. 2 opened new positions and 0 sold out. The largest holders were Envestnet Asset Management Inc. ($20K), SMH Capital Advisors Inc. ($19K) and Avantax Advisory Services, Inc. ($19K).
- Company
- Standard Biotools Inc. (lab 2.75 02/01/34)
- CUSIP
- 34385PAA6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $38K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 38,000 shares bought, net +38,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Envestnet Asset Management Inc. | 0.00% | No change | 20,000 | $20K |
| SMH Capital Advisors Inc. | 0.06% | New | 19,000 | $19K |
| Avantax Advisory Services, Inc. | 0.00% | New | 19,000 | $19K |
| Mariner, LLC | 0.00% | No change | 10,000 | $10K |
"% of holder's portfolio" is STANDARD BIOTOOLS INC (LAB 2.75 02/01/34)'s weight in each manager's 13F, not the share of Standard Biotools Inc. (lab 2.75 02/01/34) the manager owns.